Global Microbiome Sequencing Services Market Report 2022: Booming Pharmaceutical Sector Drives Growth –


DUBLIN–(BUSINESS WIRE)–The report “Microbiome Sequencing Services Market: Global Industry Trends, Share, Size, Growth, Opportunities and Forecast 2022-2027” has been added to from offer.

The global microbiome sequencing services market size reached US$1,537.3 million in 2021. Looking ahead, the publisher expects the market to reach US$4,612.0 million in 2021. 2027, posting a CAGR of 20.09% in 2021-2027. Keeping in mind the uncertainties of COVID-19, we continuously monitor and assess the direct and indirect influence of the pandemic on different end-use sectors. This information is included in the report as a major market contributor.

Microbiome sequencing services help determine the function of the microbiome in the pathogenesis of human health and disease using Next Generation Sequencing (NGS) instruments. These services provide comprehensive bioinformatics and statistical analyzes in a user-friendly and interactive report. They also offer faster and more accurate classification compared to traditional identification methods such as cloning and culture. They mainly include functional profiling, clustering heatmap, alpha diversity, beta diversity, discovery of LEfSe biomarkers and identification of taxa, antibiotic resistance genes and virulence factors. Currently, microbiome sequencing services are gaining momentum all over the world.

Microbiome Sequencing Services Market Trends:

The booming pharmaceutical sector represents one of the key factors enhancing the growth of the market. Apart from this, there is a considerable increase in the prevalence of colorectal cancer (CRC) due to the increasing number of people with inflammatory bowel diseases, the increase in the geriatric population and the increasing consumption of low-fat diets. fiber and high in fat. As a result, the demand for early disease detection and diagnosis is increasing worldwide.

This coupled with the wide applications of microbiome sequencing services in universities and research institutes for protein and small molecule analysis is positively influencing the market. Additionally, major market players are using advanced technologies including modified organoids derived from human stem cells, high-throughput culture, and microfluidics that help improve the efficiency and quality of microbiome research.

They are also focusing on the customization of gut microbial consortia to develop advanced individualized medicine. Also, due to faster and cost-effective sequencing platforms and data analysis pipelines, microbiome content is widely used as a biomarker for different diseases. Other major factors including increase in genomic research and rising healthcare expenditure are expected to drive the market growth.

Key market segmentation

Breakdown by technology:

  • Sequencing by synthesis (SBS)

  • Sequencing by ligation (SBL)

  • Pyrosequencing

  • Sanger sequencing

  • Others

Breakdown by type of research:

  • Outsourced research

  • Internal research

Breakdown by type of laboratory:

Breakdown by application:

  • Shotgun sequencing

  • Targeted gene sequencing

  • RNA sequencing

  • Whole genome sequencing

  • Others

Breakdown by end user:

  • Pharmaceutical and biotechnology companies

  • Research institutes and universities

  • Others

Breakdown by region:

  • North America

  • United States

  • Canada

  • Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Indonesia

  • Others

  • Europe

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Russia

  • Others

  • Latin America

  • Brazil

  • Mexico

  • Others

  • Middle East and Africa

Main topics covered:

1 Preface

2 Scope and methodology

3 Executive summary

4 Presentation

5 Global Microbiome Sequencing Services Market

6 Market Breakdown by Technology

7 Market Breakdown by Research Type

8 Market Breakdown by Laboratory Type

9 Market Breakdown by Application

10 Market Breakdown by End User

11 Market Breakdown by Region

12 SWOT Analysis

13 Value chain analysis

14 Analysis of the five forces of carriers

15 Price Analysis

16 Competitive landscape

Companies cited

  • BaseClear B.V.

  • Clinical Microbiology A/S

  • Diversigen Inc (OraSure Technologies Inc.)

  • Merieux NutriSciences

  • Metabiomics Corporation (BioSpherex LLC)

  • Microbiome Insights Inc.

  • Therapeutic Microbiome LLC

  • Molecular Research LP

  • Molzym GmbH & Co. KG

  • Resphera Biosciences LLC

  • Shanghai Realbio Technology (RBT) Co.Ltd.

  • Zymo Research Company.

For more information on this report visit


Laura Wood, Senior Press Officer

[email protected]
For EST business hours, call 1-917-300-0470

For the United States and Canada, call toll-free 1-800-526-8630

For GMT office hours call +353-1-416-8900


About Author

Comments are closed.